This company listing is no longer active
Chinook Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Chinook Therapeutics has a total shareholder equity of $357.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $488.8M and $131.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$297.17m |
| Equity | US$357.04m |
| Total liabilities | US$131.77m |
| Total assets | US$488.81m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 290A's short term assets ($305.4M) exceed its short term liabilities ($52.5M).
Long Term Liabilities: 290A's short term assets ($305.4M) exceed its long term liabilities ($79.3M).
Debt to Equity History and Analysis
Debt Level: 290A is debt free.
Reducing Debt: 290A had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 290A has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 290A has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 48.4% each year.